...
首页> 外文期刊>Cytometry, Part B. Clinical cytometry: the journal of the International Society for Analytical Cytology >Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia
【24h】

Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia

机译:CD43,CD81和CD200在经典与变体毛细胞白血病中的差异表达

获取原文
获取原文并翻译 | 示例
           

摘要

Background Hairy cell leukemia (HCL) and hairy cell leukemia variant (HCLv) are rare diseases with overlapping clinicopathological features. Features distinguishing HCL from HCLv include expression of CD25, CD123, CD200, annexin-A1, and the presence of BRAF V600E mutation. HCLv typically lacks these markers, but they may occur in a subgroup of HCL patients with an aggressive clinical course. We examined CD43, CD81, CD79b, and CD200 expression in HCL and HCLv. Methods Multiparametric flow cytometry (FCM) was performed on blood from 59 HCL and 15 HCLv patients for protocol entry. Mean fluorescent intensity (MFI) of CD43, CD79b, CD81, and CD200 was determined (for CD200, n = 17 and 7, respectively). Results Median MFI of HCL vs HCLv was 545 vs 272 for CD43, 602 vs 2,450 for CD81, 4,962 vs 1,969 for CD79b, and 11,652 vs 1,405 for CD200, respectively. Analysis of the median differences, HCL minus HCLv (and their 95% confidence intervals and P-values) indicated that CD43 MFI (estimated median difference (95% CI): 212 [72-413; P = 0.0027) and CD200 MFI (9,883 [3,514-13,434]; P < 0.0001) were higher in HCL than in HCLv, while CD81 MFI (-1,858 [-2,604 to -1,365]; P < 0.0001) was lower in HCL than in HCLv. CD79b MFI HCL median was more than double that of HCLv, but the observed difference (1,571 [-739 to 4,417]) was consistent with the null hypothesis of no difference (P = 0.13). Conclusions CD200, CD43, and CD81 are likely differentially expressed between HCL and HCLv, reflecting their differing disease biology. Inclusion of these markers in FCM is potentially informative. (c) 2019 International Clinical Cytometry Society
机译:背景毛细胞白血病(HCl)和毛状细胞白血病变体(HCLV)是具有重叠临床病理特征的罕见疾病。将HCl与HCLV区分的特征包括CD25,CD123,CD200,annexin-A1的表达和BRAF V600E突变的存在。 HCLV通常缺乏这些标志物,但它们可能发生在HCL患者的亚群中,临床过程。我们检查了HCl和HCLV的CD43,CD81,CD79B和CD200表达。方法对59 HCl和15例HCLV患者进行血液对血液进行多次流式细胞术(FCM)。测定CD43,CD79B,CD81和CD200的平均荧光强度(MFI)(用于CD200,N = 17和7)。结果HCl VS HCLV的中值MFI为CD43,602 Vs 2,450的CD81,4,962 vs1,969的545 Vs 272,CD79b的4,962 vs 1,969分别为CD200的11,652 vs 1,405。分析中值差异,HCl减去HCLV(及其95%置信区间和P值)表明CD43 MFI(估计中位数差(95%CI):212 [72-413; P = 0.0027)和CD200 MFI(9,883 [3,514-13,434]; p <0.0001)HCl高于HCLV,而CD81MFI(-1,858 [-2,604至-1,365]; HCl在HClV中低于HClV。 CD79B MFI HCl中值的HCLV的正常增加,但观察到的差异(1,571 [-739至4,417])与无差异的零假设一致(p = 0.13)一致。结论CD200,CD43和CD81可能在HCl和HCLV之间表达差异,反映其不同的疾病生物学。将这些标记包含在FCM中是可能的信息。 (c)2019年国际临床细胞计量

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号